<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Aggregation of human islet amyloid <z:chebi fb="1" ids="15841">polypeptide</z:chebi> (hIAPP) as islet amyloid is associated with increased beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and reduced beta cell mass in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Islet amyloid formation induces <z:mp ids='MP_0003674'>oxidative stress</z:mp>, which contributes to beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The cJUN N-terminal kinase (JNK) pathway is a critical mediator of beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in response to stress stimuli including <z:mp ids='MP_0003674'>oxidative stress</z:mp> and exogenous application of hIAPP </plain></SENT>
<SENT sid="3" pm="."><plain>We determined whether amyloid formation by endogenous hIAPP mediates beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through JNK activation and downstream signalling pathways </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: hIAPP transgenic and non-transgenic mouse islets were cultured for up to 144 h in 16.7 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> to induce islet amyloid in the presence or absence of the amyloid inhibitor <z:chebi fb="0" ids="34653">Congo Red</z:chebi> or a cell-permeable JNK inhibitor </plain></SENT>
<SENT sid="5" pm="."><plain>Amyloid, beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, JNK signalling and activation of downstream targets in the intrinsic and extrinsic apoptotic pathways were measured </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: JNK activation occurred with islet amyloid formation in hIAPP transgenic islets after 48 and 144 h in culture </plain></SENT>
<SENT sid="7" pm="."><plain>Neither high <z:chebi fb="105" ids="17234">glucose</z:chebi> nor the hIAPP transgene alone was sufficient to activate JNK independent of islet amyloid </plain></SENT>
<SENT sid="8" pm="."><plain>Inhibition of islet amyloid formation with <z:chebi fb="0" ids="34653">Congo Red</z:chebi> reduced beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and partially decreased JNK activation </plain></SENT>
<SENT sid="9" pm="."><plain>JNK inhibitor treatment reduced beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> without affecting islet amyloid </plain></SENT>
<SENT sid="10" pm="."><plain>Islet amyloid increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of markers of the extrinsic (Fas, Fadd) and intrinsic (<z:chebi fb="3" ids="33173">Bim</z:chebi> [also known as Bcl2l11]) apoptotic pathways, caspase 3 and the anti-apoptotic molecule Bclxl (also known as Bcl2l1) in a JNK-dependent manner </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: Islet amyloid formation induces JNK activation, which upregulates predominantly pro-apoptotic signals in both extrinsic and intrinsic pathways, resulting in beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>